Live Breaking News & Updates on Andrew widger

Stay informed with the latest breaking news from Andrew widger on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Andrew widger and stay connected to the pulse of your community

Pfizer Inc.: Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY

Pfizer Inc.: Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY
Additional dose deliveries beginning December 2021 through 2023
Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY to the EC since the beginning of the pandemic
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY
, the companies' COVID-19 vaccine, to the European Union (EU), with an option for the EC to request up to an additional 900 million doses.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005450/en/

United-states , Canada , United-kingdom , Sylke-maas , Albert-bourla , Chuck-triano , Andrew-widger , Ugur-sahin , Fosun-pharma , Centers-for-disease , Linkedin , Genentech

BioNTech SE: Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY

New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million dosesAdditional dose deliveries beginning December 2021 through 2023Pfizer

Germany , United-states , Canada , United-kingdom , Sylke-maas , Albert-bourla , Andrew-widger , Chuck-triano , Ugur-sahin , Fosun-pharma , Linkedin , Genentech

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®

BioNTech SE
Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million doses
Additional dose deliveries beginning December 2021 through 2023
Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY® to the EC since the beginning of the pandemic
NEW YORK AND MAINZ, GERMANY, May 20, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY

Germany , United-states , Canada , United-kingdom , Sylke-maas , Albert-bourla , Chuck-triano , Andrew-widger , Ugur-sahin , Fosun-pharma , Biontech-to-supply-the-european-union , Genentech

BioNTech SE: Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine

(0)
ISTANBUL, TURKEY and MAINZ, GERMANY,
May 20, 2021(Nasdaq: BNTX) today announced that the BioNTech Europe GmbH has entered into an agreement with Turkey's Ministry of Health to supply 60 million additional doses of the companies' COVID-19 vaccine, with an option for an additional 30 million doses. On December 25, 2020, the two companies announced an initial agreement to provide 30 million doses of the Pfizer-BioNTech vaccine to Turkey. This second supply agreement brings the total number of doses to be supplied to Turkey to up to 120 million, all of which will be delivered in 2021.
"Our goal is to deliver as many doses of our COVID-19 vaccine as possible to people around the world to help end this pandemic, reduce COVID-19-related hospitalisations and return to a normal life. We are grateful to be able to make an important contribution to Turkey's vaccination efforts and for the trust placed in us," said

Germany , Istanbul , Turkey , United-states , Canada , United-kingdom , Biontech-europe-gmb , Sylke-maas , Chuck-triano , Andrew-widger , Ugur-sahin , Fosun-pharma

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®
New agreement to supply 900 million doses to the European Commission with option to request up to an additional 900 million doses Additional dose deliveries beginning December 2021 through 2023 Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY® to the EC since the beginning of the pandemic Pfizer Inc. and BioNTech SE today announced a new agreement with the European Commission …
New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million doses

United-states , Canada , United-kingdom , Sylke-maas , Albert-bourla , Chuck-triano , Andrew-widger , Ugur-sahin , Fosun-pharma , Centers-for-disease , Linkedin , Genentech

WHO head pushes countries and companies to waive rights to coronavirus vaccines, in bid to broaden access

WHO head pushes countries and companies to waive rights to coronavirus vaccines, in bid to broaden access
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

South-africa , United-states , India , United-kingdom , Senegal , Dakar , Washington , Britain , Adam-hodge , Krishna-udayakumar , Andrew-widger , Pfizer

Pfizer Inc.: EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

(2)
- If approved, somatrogon will serve as a once-weekly treatment option -
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for somatrogon, a long-acting recombinant human growth hormone that is intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency (GHD). Pfizer expects a decision from the European Commission in 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210226005102/en/
"Today's announcement is an example of our decades-long commitment to actively support the pediatric growth hormone deficiency community through therapeutic options that help children reach their full potential," said Brenda Cooperstone, MD, Chief Development Officer, Rare Disease, Pfizer Global Product Development. "If approved in the EU, somatrogon will represent an important advancement, as this long-acting, weekly treatment may reduce the burden of daily injections on children, their loved ones, and caregivers. We look forward to continuing to work with the EMA to evolve the treatment paradigm for pediatric patients with growth hormone deficiency."

Japan , United-states , Andrew-widger , Chuck-triano , Phillip-frost , Brenda-cooperstone , Linkedin , European-commission , Pfizer-global-product-development , Health-inc , Nasdaq , Pfizer

Police probe side offers of COVID vaccines to Italian regions

HEALTH-CORONAVIRUS/ITALY-VACCINES (PIX):Police probe side offers of COVID vaccines to Italian regions

Germany , New-york , United-states , Milan , Lombardia , Italy , United-kingdom , Umbria , Veneto , Sweden , Russia , Italian

Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Press release content from Business Wire. The AP news staff was not involved in its creation.
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
February 17, 2021 GMT
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Feb 17, 2021--
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY ®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses.
ADVERTISEMENT
This new agreement is in addition to the 300 million doses that have already been committed to the EU through 2021 under the first supply agreement signed last year. The additional 200 million doses are expected to be delivered in 2021, with an estimated 75 million to be supplied in the second quarter.

United-states , Canada , United-kingdom , Sylke-maas , Albert-bourla , Chuck-triano , Andrew-widger , Ugur-sahin , Fosun-pharma , Centers-for-disease , Linkedin , Genentech

BioNTech SE: Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021European Commission has the option to request an additional 100 million doses NEW

Germany , United-states , Canada , United-kingdom , Sylke-maas , Albert-bourla , Chuck-triano , Andrew-widger , Ugur-sahin , Fosun-pharma , Linkedin , Genentech